TRILAFON Drug Patent Profile
✉ Email this page to a colleague
When do Trilafon patents expire, and when can generic versions of Trilafon launch?
Trilafon is a drug marketed by Schering and is included in five NDAs.
The generic ingredient in TRILAFON is perphenazine. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the perphenazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trilafon
A generic version of TRILAFON was approved as perphenazine by SANDOZ on December 8th, 1988.
Summary for TRILAFON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,208 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRILAFON at DailyMed |
Recent Clinical Trials for TRILAFON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sunovion | Phase 4 |
| University of Texas Southwestern Medical Center | Phase 4 |
| National Institute of Mental Health (NIMH) | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TRILAFON
US Patents and Regulatory Information for TRILAFON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | TRILAFON | perphenazine | CONCENTRATE;ORAL | 011557-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | TRILAFON | perphenazine | TABLET;ORAL | 010775-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | TRILAFON | perphenazine | TABLET, EXTENDED RELEASE;ORAL | 011361-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | TRILAFON | perphenazine | TABLET;ORAL | 010775-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | TRILAFON | perphenazine | INJECTABLE;INJECTION | 011213-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | TRILAFON | perphenazine | SYRUP;ORAL | 011294-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
